LONDON — GlaxoSmithKline is making a donation that it said would give more than 10,000 girls and women access to human papillomavirus vaccination.
GSK announced that it would donate $1 million worth of Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant) to the Pink Ribbon Red Ribbon Partnership over the next five years, as well as $50,000 to support the program operations. The partnership is an initiative led by Susan G. Komen for the Cure, UNAIDS, the President's Emergency Relief Plan for AIDS Relief and the George W. Bush Institute.
"We share the Pink Ribbon Red Ribbon Partnership's commitment to identifying and developing innovative models that will effectively educate patients and healthcare providers in developing countries about cancer prevention," GSK SVP developing countries and marketing access Duncan Learmouth said. "It is a sad reality that each year, thousands of women are diagnosed with cervical cancer, a potentially preventable cancer."